Evidence map›Paper›PMID 32424483›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

The image quality, lesion detectability, and acquisition time of

Yi-Qiu Zhang, Peng-Cheng Hu, Run-Ze Wu, Yu-Shen Gu, Shu-Guang Chen, Hao-Jun Yu, Xiang-Qing Wang, Jun Song, Hong-Cheng Shi

3 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04654234 completednot on this map

Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy

Typeobservational_patient_registrySponsorSun Yat-sen UniversityRan2020 to 2023Enrolled15ConditionsNon-small Cell Lung CancerArmsTotal body PET/CT (uExplorer)
NCT04931875 unknown statusnot on this mapstarted 2021, after this paper: background citation

Total-body 18F-FDG PET / CT in the Evaluation of Treatment and Prognosis of Patients With Lymphoma

TypeobservationalSponsorRenJi HospitalRan2021 to 2024Enrolled100ConditionsLymphomaArmsTotal body PET/CT (uExplorer)
NCT05468242 phase2recruitingnot on this mapstarted 2022, after this paper: background citation

A Phase II Trial of Tislelizumab as Consolidation Therapy in Patients With Locally Advanced Non-Small Cell Lung Cancer Who Have Not Progressed Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy

TypeinterventionalSponsorSun Yat-sen UniversityRan2022 to 2024Enrolled116ConditionsStage III Non-small Cell Lung CancerArmsNeoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy, Tislelizumab
3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Trial
  2. Review
  3. Exploring the feasibility of a 40-minute uptake time for long axial field of view [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Lung lesion detectability on images obtained from decimated and CNN-based denoised [European journal of nuclear medicine and molecular imaging · 2025
    Article
  5. Assessment of reducedAnnals of nuclear medicine · 2025
    Article
  6. Data-efficient generalization of AI transformers for noise reduction in ultra-fast lung PET scans.European journal of nuclear medicine and molecular imaging · 2025
    Article
  7. Leveraging small voxel with optimal acquisition time for [European journal of nuclear medicine and molecular imaging · 2025
    Article
  8. Article
  9. Expert consensus on workflow of PET/CT with long axial field-of-view.European journal of nuclear medicine and molecular imaging · 2025
    Review
  10. Role of Total Body PET/CT in Inflammatory Disorders.Seminars in nuclear medicine · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. EJNMMI physics · 2024
    Article
  15. Article
  16. KineticEJNMMI physics · 2024
    Article
  17. Article
  18. Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [European journal of nuclear medicine and molecular imaging · 2024
    Article
  19. Article
  20. Reduced count pediatric whole-bodyPediatric radiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yi-Qiu Zhang *Department of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd., Shanghai, China.
Peng-Cheng Hu *Department of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd., Shanghai, China.
Run-Ze WuUnited Imaging Research, Shanghai, China.
Yu-Shen GuDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd., Shanghai, China.
Shu-Guang ChenDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd., Shanghai, China.
Hao-Jun YuDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd., Shanghai, China.
Xiang-Qing WangDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd., Shanghai, China.
Jun SongDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd., Shanghai, China.
Hong-Cheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd., Shanghai, China. Shi.hongcheng@zs-hospital.sh.cn.

Funding

National Key Research and Development Program of China 2016YFC10103908National Natural Science Foundation of China 81471706 and 81671735Shanghai Municipal Population and Family Planning Commission 20164Y0113Shanghai Science and Technology Development Foundation 17511104201
6 · The paper itself

Abstract

purposeThe purpose was to investigate the effects of short acquisition time on the image quality and the lesion detectability of oncological

methodsNineteen oncological patients (6/13 women/men, age 65.6 ± 9.4 years) underwent total-body PET/CT on uEXPLORER scanner using 3D list mode. The administration of

resultsOur results showed that sufficient and acceptable subjective image quality could be achieved with 60- and 30-s groups, and good image quality scores were given to 180- and 120-s groups without significant difference. For shortened acquisition time, SD was increased, while SUV

conclusionThe total-body PET/CT can significantly shorten the acquisition time with maintained lesion detectability and image quality.

Indexed as

Fluorodeoxyglucose F18NeoplasmsAgedFemaleHumansMaleMiddle AgedPositron-Emission TomographyPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18FDGImage qualityLesion detectabilityPET/CTShort acquisition timeTotal-body PET

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.